60 results
8-K
EX-4.2
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.5
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.1
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.3
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.4
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.1
xsfzm
9 May 23
Jaguar Completes Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea
8:30am
8-K
EX-4.1
spkfte42pqc2ddfdzfy2
30 Aug 22
Jaguar Health Secures Additional Capital Through Sale of Royalty Rights Related to Future Crofelemer and Lechlemer Revenue Stream
4:30pm
8-K
EX-4.4
jl0a1zep 28kyf
15 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-4.1
zkzbves7 em
15 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-4.3
iarxky82me f0
15 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-4.2
r1u5wl
15 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-4.1
90q4jq4j1l2g
8 Apr 21
Entry into a Material Definitive Agreement
5:21pm
8-K
EX-4.1
x112fhgdzfd6m 5r5g
11 Mar 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-4.1
r99nnck36gk8vplutbc
22 Jan 21
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-4.1
0mllgp59j70q
29 Dec 20
Jaguar Health Reports Voting Results from Special Meeting of Stockholders & Announces December 23rd Investor Webinar
5:03pm
8-K
EX-4.1
pfo8 0256yujdbpqt1g
9 Oct 20
Entry into a Material Definitive Agreement
4:40pm
8-K
EX-4.1
izh8an hx
9 Oct 20
Entry into a Material Definitive Agreement
4:18pm
8-K
EX-4.1
5mkagn0zv7xd2ggak
2 Sep 20
Entry into a Material Definitive Agreement
8:25am
8-K
EX-4.1
n5qedfvp7gr k9304
22 May 20
Entry into a Material Definitive Agreement
5:25pm